Condition
Advanced Breast Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Advanced Breast Carcinoma clinical trials that are recruiting, at sites in 11 countries (most in United States (4), Austria (1), Belgium (1)). By phase: Phase 2 (3), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 11Countries
Newest Advanced Breast Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Living Well with Advanced Breast Cancer: Understanding Supportive Care Needs | — | Columbus, Ohio | Recruiting | Nov 12, 2025 |
| Trastuzumab deruxtecan versus CDK4/6 inhibitor plus hormone therapy as first-line treatment for HR-positive, HER2-low non-luminal advanced breast cancer. | Phase 2 | Graz and 78 other locations | Recruiting | Jul 5, 2024 |
| At-home cancer treatment versus clinic-based treatment for advanced cancer patients | Phase 2 | Jacksonville, Florida and 1 other locations | Recruiting | Aug 1, 2023 |
| Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors | Phase 1 | Houston, Texas | Recruiting | Oct 25, 2021 |
| Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations | Phase 2 | Houston, Texas | Recruiting | Sep 16, 2019 |
All recruiting trials (5)
-
Living Well with Advanced Breast Cancer: Understanding Supportive Care Needs
This project asks adults with advanced (stage IV) breast cancer and their caregivers about what supportive care has helped, what’s been hard, and what help they still need.
-
Trastuzumab deruxtecan versus CDK4/6 inhibitor plus hormone therapy as first-line treatment for HR-positive, HER2-low non-luminal advanced breast cancer.
This trial will see if trastuzumab deruxtecan (T-DXd) works better than a CDK4/6 inhibitor plus endocrine (hormone) therapy as first-line treatment for adults with HR-positive, HER2-low advanced breast cancer that is classified as non-luminal by gene profiling.
-
At-home cancer treatment versus clinic-based treatment for advanced cancer patients
This study tests whether giving cancer treatment at home is better for comfort and satisfaction compared to getting it at a clinic for people with advanced cancer.
-
Combining Tumor Treating Fields with Cabozantinib or Pembrolizumab and Nab-Paclitaxel for Advanced Solid Tumors
This study is testing a new treatment that combines tumor treating fields with two different cancer drugs to see if it helps people with advanced solid tumors in the abdomen or chest.
-
Combining Olaparib with Cediranib or AZD6738 for Advanced Breast Cancer with BRCA Mutations
This study is testing if combining the drugs olaparib with either cediranib or AZD6738 can help women with advanced breast cancer that has BRCA mutations feel better after they’ve already tried other treatments.
Related topics
Quick answers
How many Advanced Breast Carcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 11 countries. The most sites are in United States (4 trials), Austria (1 trial), Belgium (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.